...
首页> 外文期刊>Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society >High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.
【24h】

High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation.

机译:肝癌手术切除后复发的高病理风险:挽救肝移植的指征。

获取原文
获取原文并翻译 | 示例
           

摘要

Surgical resection and liver transplantation offer a 5-year survival greater than 70% in patients with hepatocellular carcinoma, but the high recurrence rate impairs long-term outcome after resection. Pathological data such as vascular invasion and detection of additional nodules predict recurrence and divide patients into high and low risk profile. Based on this, we proposed salvage liver transplant to resected patients in whom pathology evidenced high recurrence risk even in the absence of proven residual disease. From January 1995 to August 2003 we have evaluated 1,638 patients. Resection was indicated in 77 patients, but only 17 (22%) (all cirrhotics, 14 hepatitis C virus+) were optimal candidates for both resection and transplantation. Of them, 8 exhibited a high risk profile at pathology and were offered transplantation. Among the 8 high risk patients, 7 presented recurrence, compared with only 2 of the 9 at low risk (P = .012). Two of the high risk patients refused transplant and developed multifocal disease during follow-up. The other 6 were enlisted and all but 1 had tumor foci in the explant. Only 1 presented extrahepatic dissemination early after transplant and died 4 months later. The others are free of disease after a median follow-up of 45 months. Two recurrences were detected in low risk patients, 1 of them being transplanted 18 months after surgery. These data in a small series of patients confirm that pathological parameters identify patients at higher risk of recurrence, which allow them to be listed for liver transplantation without proven malignant disease. In conclusion, this policy is clinically effective and could further improve the outcome of resected patients.
机译:肝癌患者手术切除和肝移植可以提供大于70%的5年生存率,但是高复发率损害了切除后的长期预后。诸如血管浸润和其他结节的检测等病理数据可预测复发,并将患者分为高危和低危。基于此,我们提出了挽救性肝移植的目标,这些患者即使没有确诊的残留疾病也被病理证实具有高复发风险。从1995年1月到2003年8月,我们评估了1,638例患者。有77例患者需要切除,但只有17例(22%)(所有肝硬化患者,14例丙型肝炎病毒+)是切除和移植的最佳候选者。其中有8例在病理上表现出高风险,并接受了移植。在8位高危患者中,有7位复发,而9位低危患者中只有2位复发(P = .012)。两名高危患者在随访期间拒绝移植并发展为多灶性疾病。招募了其他6名,除1名外,其他均在外植体中有肿瘤灶。仅有1例在移植后早期出现肝外扩散,并在4个月后死亡。在中位随访45个月后,其他患者没有疾病。低危患者中有2例复发,其中1例在术后18个月被移植。在少量患者中的这些数据证实了病理学参数可识别出复发风险更高的患者,这使他们可以被列为肝移植而无经证实的恶性疾病。总之,该政策在临床上是有效的,并且可以进一步改善切除患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号